Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis
dc.contributor.author | Koparal, Mahmut | |
dc.contributor.author | Gulsun, Belgin | |
dc.contributor.author | Deveci, Engin | |
dc.contributor.author | Agacayak, K. Serkan | |
dc.contributor.author | Hamidi, Arif | |
dc.date.accessioned | 2024-04-24T17:47:33Z | |
dc.date.available | 2024-04-24T17:47:33Z | |
dc.date.issued | 2016 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | OBJECTIVE: To determine the effect of zoledronic acid on graft materials in bone calvarial defects. STUDY DESIGN: Eighty adult (12 weeks) Sprague-Dawley male rats weighing from 300-350 g were divided into groups: calvarial defect, calvarial defect + synthetic graft, and calvarial defect + xenograft. All groups received zoledronate intravenously for a week after surgery and were sacrificed at either 6 or 12 weeks after their operation. The rat calvariae were fixed in 10% neutral buffered formalin before decalcification in 10% ethylenediaminetetraacetic acid for 20 days. Calvarial bone samples were then dehydrated and processed for embedding in paraffin wax. Sections 5 ?m thick were stained with hematoxylin and eosin and examined by light microscopy. RESULTS: The effects of zoledronic acid, a third-generation nitrogen-containing bisphosphonate, on different graft materials in rats with critical-size calvarial defects were analyzed and compared. Significantly less graft resorption was identified in zoledronic acid-treated rats that had received a xenograft than in either the untreated rats or those with a synthetic graft. In the xenograft group primary ossification was visible at week 12, and the graft had entered the bone to a greater extent than in the other experimental groups or in the control group. Osseous structures were also observed more clearly in this group than in the others. CONCLUSION: Zoledronic acid histopathologic bone graft stimulates bone formation. Zoledronic acid may be considered among the therapeutic methods available to improve the bone formation process in calvarial bone formation. | en_US |
dc.identifier.endpage | 125 | en_US |
dc.identifier.issn | 0884-6812 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 27386633 | |
dc.identifier.startpage | 117 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/22594 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:000381062200008 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Sci Printers & Publ Inc | en_US |
dc.relation.ispartof | Analytical and Quantitative Cytopathology and Histopathology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Antiresorptive Drugs | en_US |
dc.subject | Bone Defect | en_US |
dc.subject | Bone Dysplasias | en_US |
dc.subject | Bone Grafts | en_US |
dc.subject | Bone Regeneration | en_US |
dc.subject | Bone Remodeling | en_US |
dc.subject | Bone Resorption | en_US |
dc.subject | Bone Resorption Inhibitors | en_US |
dc.subject | Bone Resorption Inhibitory Agents | en_US |
dc.subject | Develop Mental Bone Disease | en_US |
dc.subject | Fracture Healing | en_US |
dc.subject | Osteoconduction | en_US |
dc.subject | Zoledronate | en_US |
dc.subject | Zoledronic Acid | en_US |
dc.title | Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis | en_US |
dc.title | Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis | |
dc.type | Article | en_US |